These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lewis W; Grupp IL; Grupp G; Hoit B; Morris R; Samarel AM; Bruggeman L; Klotman P Lab Invest; 2000 Feb; 80(2):187-97. PubMed ID: 10701688 [TBL] [Abstract][Full Text] [Related]
25. Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher. Masland T; King P Newsweek; 2000 Apr; 135(16):36. PubMed ID: 10848182 [No Abstract] [Full Text] [Related]
26. Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity. Frissen PH; de Vries J; Weigel HM; Brinkman K AIDS; 2001 Jan; 15(2):289. PubMed ID: 11216946 [No Abstract] [Full Text] [Related]
27. Antiretroviral rounds. When success is a pain. Bartlett JG; del Rio C AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461 [No Abstract] [Full Text] [Related]
28. Maintaining a low viral load with Nevirapine? TreatmentUpdate; 1998 Dec; 10(10):3-4. PubMed ID: 11366017 [TBL] [Abstract][Full Text] [Related]
29. [Thrombocytosis and cholestasis in a newborn treated with zidovudine]. Bruel H; Chabrolle JP; el Khoury E; Poinsot J; el Forzi N; Amusini P; Col JY Arch Pediatr; 2001 Aug; 8(8):893-4. PubMed ID: 11524922 [No Abstract] [Full Text] [Related]
30. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Walker VE; Poirier MC Environ Mol Mutagen; 2007; 48(3-4):159-65. PubMed ID: 17358025 [No Abstract] [Full Text] [Related]
33. Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV. Yamamoto Y; Yasuoka A; Tachikawa N; Teruya K; Genka I; Yamaguchi M; Yasuoka C; Kikuchi Y; Aoki M; Oka S Jpn J Infect Dis; 1999 Dec; 52(6):248-9. PubMed ID: 10738365 [No Abstract] [Full Text] [Related]
34. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227 [TBL] [Abstract][Full Text] [Related]
35. The role of zidovudine in development of lipoatrophy. Moyle GJ AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181 [No Abstract] [Full Text] [Related]
36. Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs. Stojanov S; Wintergerst U; Belohradsky BH; Rolinski B AIDS; 2000 Jul; 14(11):1669. PubMed ID: 10983660 [No Abstract] [Full Text] [Related]
37. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A; Rutherford GW; Siegfried N Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777 [TBL] [Abstract][Full Text] [Related]
38. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314 [TBL] [Abstract][Full Text] [Related]